The Glucagonoma Syndrome: A Distinctive Cutaneous Marker of Systemic Disease

Keith H. Swenson, Robert B. Amon, Jon M. Hanifin

Research output: Contribution to journalArticle

34 Scopus citations

Abstract

The glucagonoma syndrome is a rare clinical condition characterized by a distinctive cutaneous eruption associated with a glucagon-secreting islet cell neoplasm of the pancreas. A 19-year-old woman manifested typical features of this condition: a polymorphous skin eruption with characteristic distribution of lesions in perioral and paragenital regions; lesions in sites of cutaneous trauma; a skin biopsy that showed epidermal cleavage; glossitis; weight loss; mild anemia; abnormal glucose tolerance test results. Plasma glucagon levels, determined by radioimmunoassay, were approximately five times normal. Angiography indicated a pancreatic tumor with liver metastases. Islet cell origin was confirmed histologically. It is hoped that wider recognition of the distinctive clinical features of this syndrome will result in earlier detection and possible surgical cure of the underlying malignancy.

Original languageEnglish (US)
Pages (from-to)224-228
Number of pages5
JournalArchives of dermatology
Volume114
Issue number2
DOIs
StatePublished - Feb 1978

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'The Glucagonoma Syndrome: A Distinctive Cutaneous Marker of Systemic Disease'. Together they form a unique fingerprint.

  • Cite this